NeoPharm CO. LTD (092730) — Free Cash Flow Generation Index
NeoPharm CO. LTD (092730) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩5.43 Billion represents 1% of operating cash flow (₩5.88 Billion). See NeoPharm CO. LTD (092730) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NeoPharm CO. LTD Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for NeoPharm CO. LTD across 11 annual periods. Explore 092730 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for NeoPharm CO. LTD (2012–2024)
Year-by-year Free Cash Flow Generation Index for NeoPharm CO. LTD. For the full company profile including market capitalisation, see 092730 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.83x | ₩15.55 Billion | ₩18.63 Billion | ₩3.08 Billion | ▲ +697.6% |
| 2023 | 0.10x | ₩2.43 Billion | ₩23.26 Billion | ₩20.83 Billion | ▼ -89.0% |
| 2022 | 0.96x | ₩17.35 Billion | ₩18.16 Billion | ₩806.43 Million | ▼ -2.3% |
| 2021 | 0.98x | ₩21.20 Billion | ₩21.68 Billion | ₩320.11 Million | ▲ +2.2% |
| 2020 | 0.96x | ₩16.34 Billion | ₩17.07 Billion | ₩285.62 Million | ▼ -17.5% |
| 2019 | 1.16x | ₩22.31 Billion | ₩19.22 Billion | ₩5.90 Billion | ▲ +3.6% |
| 2018 | 1.12x | ₩18.12 Billion | ₩16.18 Billion | ₩1.94 Billion | ▲ +3.4% |
| 2017 | 1.08x | ₩11.53 Billion | ₩10.65 Billion | ₩884.71 Million | ▼ -6.1% |
| 2016 | 1.15x | ₩10.56 Billion | ₩9.16 Billion | ₩1.40 Billion | ▲ +2.2% |
| 2015 | 1.13x | ₩6.88 Billion | ₩6.09 Billion | ₩786.89 Million | ▼ -13.5% |
| 2012 | 1.31x | ₩736.81 Million | ₩564.34 Million | ₩172.47 Million | — |